Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferric ion binding protein is a component of bacterial iron acquisition pathways, notably in pathogens such as Pasteurella, Neisseria, and Haemophilus. It resides in the periplasm and captures iron from host sources, presenting it to an ATP-binding cassette transporter for internalization. Structurally, FbpA consists of two globular domains connected by β-strands that act as a hinge, forming a binding cleft that tightly coordinates a single Fe^3+^ ion with the help of specific amino acid ligands and an anion. Its role in microbial virulence, by facilitating efficient iron uptake, makes FbpA a potential antibacterial target, and experimental studies have explored inhibitors that block its function. No FbpA-targeting drugs are currently approved. FbpA homologs are regarded as functional equivalents of transferrin for bacteria[3][4][1].
Competitive inhibition or blocking of iron binding to FbpA or disruption of associated transport systems limits iron uptake, inhibiting bacterial growth and virulence potential
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferric ion binding protein A (FbpA).